ZA200903496B - Spiro-piperidine derivatives as via receptor antagonists - Google Patents
Spiro-piperidine derivatives as via receptor antagonistsInfo
- Publication number
- ZA200903496B ZA200903496B ZA200903496A ZA200903496A ZA200903496B ZA 200903496 B ZA200903496 B ZA 200903496B ZA 200903496 A ZA200903496 A ZA 200903496A ZA 200903496 A ZA200903496 A ZA 200903496A ZA 200903496 B ZA200903496 B ZA 200903496B
- Authority
- ZA
- South Africa
- Prior art keywords
- spiro
- receptor antagonists
- piperidine derivatives
- via receptor
- piperidine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Reproductive Health (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Hospice & Palliative Care (AREA)
- Endocrinology (AREA)
- Gastroenterology & Hepatology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06125634 | 2006-12-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200903496B true ZA200903496B (en) | 2010-03-31 |
Family
ID=39295880
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200903496A ZA200903496B (en) | 2006-12-07 | 2009-05-20 | Spiro-piperidine derivatives as via receptor antagonists |
Country Status (21)
Country | Link |
---|---|
US (3) | US20080139554A1 (fr) |
EP (1) | EP2102207B1 (fr) |
JP (1) | JP2010511661A (fr) |
KR (1) | KR101050568B1 (fr) |
CN (1) | CN101547923A (fr) |
AR (1) | AR064135A1 (fr) |
AT (1) | ATE469900T1 (fr) |
AU (1) | AU2007328995B2 (fr) |
BR (1) | BRPI0720004A2 (fr) |
CA (1) | CA2670674A1 (fr) |
CL (1) | CL2007003482A1 (fr) |
DE (1) | DE602007006990D1 (fr) |
ES (1) | ES2344131T3 (fr) |
IL (1) | IL198544A (fr) |
MX (1) | MX2009005504A (fr) |
NO (1) | NO20091830L (fr) |
PE (1) | PE20081252A1 (fr) |
RU (1) | RU2009119394A (fr) |
TW (1) | TW200838518A (fr) |
WO (1) | WO2008068185A1 (fr) |
ZA (1) | ZA200903496B (fr) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2009123133A (ru) | 2006-12-22 | 2011-01-27 | Ф.Хоффманн-Ля Рош Аг (Ch) | Производные спиро-пиперидина |
ES2447590T3 (es) | 2008-04-29 | 2014-03-12 | Novartis Ag | Derivados de espiro-indol para el tratamiento de enfermedades parasitarias |
MX2017006294A (es) * | 2014-11-14 | 2017-08-21 | Hoffmann La Roche | Espiro-tiazolonas. |
WO2017137334A1 (fr) * | 2016-02-08 | 2017-08-17 | F. Hoffmann-La Roche Ag | Spiroindolinones utilisés en tant qu'inhibiteurs de ddr1 |
ES2951874T3 (es) * | 2017-09-05 | 2023-10-25 | Neumora Therapeutics Inc | Antagonistas del receptor de vasopresina y productos y métodos relacionados con los mismos |
Family Cites Families (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3370091A (en) | 1964-06-15 | 1968-02-20 | Hoffmann La Roche | 2 aminobenzhydrylhalides |
US3531467A (en) | 1966-12-23 | 1970-09-29 | Hoffmann La Roche | Process for the preparation of 2,3,4,5-tetrahydro - 5 - aryl - 1h - 1,4 - benzodiazepine derivatives |
US4209625A (en) | 1977-04-21 | 1980-06-24 | American Hoechst Corporation | Spiro[indoline-3,4'-piperidine]s |
DE3818830A1 (de) | 1988-06-03 | 1989-12-14 | Boehringer Mannheim Gmbh | Bicyclische carboxamide, verfahren zu ihrer herstellung, deren vorstufen, und diese verbindungen enthaltende arzneimittel |
EP0450761A1 (fr) * | 1990-03-02 | 1991-10-09 | Merck & Co. Inc. | Antagonistes d'oxytocine spirocycliques |
DK78692D0 (da) | 1992-06-12 | 1992-06-12 | Lundbeck & Co As H | Dimere piperidin- og piperazinderivater |
CA2143117A1 (fr) | 1992-10-07 | 1994-04-14 | Ben E. Evans | Antagonistes du recepteur de l'oxytocine de la tocolyse |
US5670509A (en) * | 1993-09-27 | 1997-09-23 | Merck & Co., Inc. | Tocolytic oxytocin receptor antagonists |
IT1271026B (it) | 1994-10-21 | 1997-05-26 | Isagro Ricerca Srl | Derivati dell'acido b-amminopropionico ad attivita' fungicida |
US5576321A (en) | 1995-01-17 | 1996-11-19 | Eli Lilly And Company | Compounds having effects on serotonin-related systems |
PL327146A1 (en) | 1995-12-14 | 1998-11-23 | Merck & Co Inc | Antagonists of the gonadotrophin liberating hormone |
GB9601724D0 (en) | 1996-01-29 | 1996-03-27 | Merck Sharp & Dohme | Therapeutic agents |
US6166209A (en) | 1997-12-11 | 2000-12-26 | Hoffmann-La Roche Inc. | Piperidine derivatives |
CO5150201A1 (es) | 1998-09-07 | 2002-04-29 | Hoffmann La Roche | Derivados de piperidina |
TWI279402B (en) | 1999-08-20 | 2007-04-21 | Banyu Pharma Co Ltd | Spiro compounds having NPY antagonistic activities and agents containing the same |
GB0003397D0 (en) | 2000-02-14 | 2000-04-05 | Merck Sharp & Dohme | Therapeutic agents |
ATE255578T1 (de) | 2000-05-12 | 2003-12-15 | Solvay Pharm Bv | Piperazin- und piperidinverbindungen |
ATE266031T1 (de) | 2000-09-29 | 2004-05-15 | Lilly Co Eli | Verfahren und verbindungen zur behandlung proliferativer erkrankungen |
CA2467825A1 (fr) | 2001-11-27 | 2003-06-05 | F. Hoffmann-La Roche Ag | Derives de benzothiazole |
FR2833948B1 (fr) | 2001-12-21 | 2004-02-06 | Sod Conseils Rech Applic | Nouveaux derives de benzimidazole et leur utilisation en tant que medicament |
US20040152741A1 (en) | 2002-09-09 | 2004-08-05 | Nps Allelix Corporation | Arylglycine derivatives and their use as glycine transport inhibitors |
AU2003263155A1 (en) | 2002-09-20 | 2004-04-08 | H. Lundbeck A/S | Method for manufacture of dihydroisobenzofuran derivatives |
MXPA05003948A (es) | 2002-10-17 | 2005-06-17 | Amgen Inc | Derivados de bencimidazol y su uso como ligandos de receptor vaniloide. |
WO2004069809A1 (fr) | 2003-02-03 | 2004-08-19 | Janssen Pharmaceutica N.V. | Mercaptoimidazoles en tant qu'agonistes du recepteur ccr2 |
US7244852B2 (en) | 2003-02-27 | 2007-07-17 | Abbott Laboratories | Process for preparing 2-methylpyrrolidine and specific enantiomers thereof |
ATE467616T1 (de) * | 2003-04-11 | 2010-05-15 | High Point Pharmaceuticals Llc | Verbindungen mit aktivität an der 11beta- hydroxasteroiddehydrogenase |
CA2544602A1 (fr) | 2003-11-04 | 2005-05-26 | Elixir Pharmaceuticals, Inc. | Composes therapeutiques et utilisations correspondantes |
EP1701959A1 (fr) * | 2003-12-22 | 2006-09-20 | Pfizer Limited | Dérivés de triazole comme antagonistes de vasopréssine |
AU2004309419A1 (en) | 2003-12-23 | 2005-07-14 | Arena Pharmaceuticals, Inc. | Novel spiroindoline or spiroisoquinoline compounds, methods of use and compositions thereof |
GB0400700D0 (en) * | 2004-01-13 | 2004-02-18 | Pfizer Ltd | Compounds useful in therapy |
AU2005268893B2 (en) | 2004-08-05 | 2011-10-13 | F. Hoffmann-La Roche Ag | Indole, indazole or indoline derivatives |
US8138342B2 (en) | 2004-10-12 | 2012-03-20 | High Point Pharmacueticals, LLC | 11β-hydroxysteroid dehydrogenase type 1 active spiro compounds |
JP4935356B2 (ja) * | 2004-10-13 | 2012-05-23 | ソニー株式会社 | 再生装置、撮像装置および画面表示方法 |
US20080234252A1 (en) | 2005-05-18 | 2008-09-25 | Pfizer Inc | Compounds Useful in Therapy |
US8190027B2 (en) | 2006-07-12 | 2012-05-29 | Tellabs Operations, Inc. | Multifunctional and reconfigurable optical node and optical network |
SI1904477T1 (sl) * | 2005-07-14 | 2009-06-30 | Hoffmann La Roche | Derivati indol-3-karbonil-spiro-piperidina kot antagonisti V1A receptorja |
WO2007028638A1 (fr) | 2005-09-09 | 2007-03-15 | Euro-Celtique S.A. | Composes fondus et spirocycle ainsi que l'utilisation de ceux-ci |
RU2009123133A (ru) | 2006-12-22 | 2011-01-27 | Ф.Хоффманн-Ля Рош Аг (Ch) | Производные спиро-пиперидина |
WO2008080844A1 (fr) | 2006-12-29 | 2008-07-10 | F. Hoffmann-La Roche Ag | Dérivés azaspiro |
KR101129791B1 (ko) | 2007-01-12 | 2012-03-23 | 에프. 호프만-라 로슈 아게 | 스파이로피페리딘 글리신아마이드 유도체 |
-
2007
- 2007-11-29 CA CA002670674A patent/CA2670674A1/fr not_active Abandoned
- 2007-11-29 JP JP2009539707A patent/JP2010511661A/ja active Pending
- 2007-11-29 AT AT07847502T patent/ATE469900T1/de active
- 2007-11-29 DE DE602007006990T patent/DE602007006990D1/de active Active
- 2007-11-29 CN CNA2007800448317A patent/CN101547923A/zh active Pending
- 2007-11-29 EP EP07847502A patent/EP2102207B1/fr not_active Not-in-force
- 2007-11-29 BR BRPI0720004-8A patent/BRPI0720004A2/pt not_active IP Right Cessation
- 2007-11-29 RU RU2009119394/04A patent/RU2009119394A/ru not_active Application Discontinuation
- 2007-11-29 WO PCT/EP2007/062985 patent/WO2008068185A1/fr active Application Filing
- 2007-11-29 KR KR1020097011665A patent/KR101050568B1/ko not_active IP Right Cessation
- 2007-11-29 AU AU2007328995A patent/AU2007328995B2/en not_active Expired - Fee Related
- 2007-11-29 MX MX2009005504A patent/MX2009005504A/es active IP Right Grant
- 2007-11-29 ES ES07847502T patent/ES2344131T3/es active Active
- 2007-11-30 US US11/947,967 patent/US20080139554A1/en not_active Abandoned
- 2007-11-30 US US11/947,953 patent/US8202993B2/en not_active Expired - Fee Related
- 2007-11-30 US US11/947,934 patent/US20080146568A1/en not_active Abandoned
- 2007-12-04 TW TW096146114A patent/TW200838518A/zh unknown
- 2007-12-04 CL CL200703482A patent/CL2007003482A1/es unknown
- 2007-12-05 AR ARP070105426A patent/AR064135A1/es unknown
- 2007-12-06 PE PE2007001736A patent/PE20081252A1/es not_active Application Discontinuation
-
2009
- 2009-05-04 IL IL198544A patent/IL198544A/en not_active IP Right Cessation
- 2009-05-11 NO NO20091830A patent/NO20091830L/no not_active Application Discontinuation
- 2009-05-20 ZA ZA200903496A patent/ZA200903496B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
CN101547923A (zh) | 2009-09-30 |
KR20090079255A (ko) | 2009-07-21 |
PE20081252A1 (es) | 2008-09-04 |
NO20091830L (no) | 2009-07-06 |
EP2102207A1 (fr) | 2009-09-23 |
IL198544A (en) | 2012-06-28 |
JP2010511661A (ja) | 2010-04-15 |
AU2007328995A1 (en) | 2008-06-12 |
US20080139554A1 (en) | 2008-06-12 |
IL198544A0 (en) | 2010-02-17 |
US20080146568A1 (en) | 2008-06-19 |
WO2008068185A1 (fr) | 2008-06-12 |
ES2344131T3 (es) | 2010-08-18 |
RU2009119394A (ru) | 2011-01-20 |
KR101050568B1 (ko) | 2011-07-19 |
AU2007328995B2 (en) | 2012-04-26 |
TW200838518A (en) | 2008-10-01 |
BRPI0720004A2 (pt) | 2013-12-17 |
US8202993B2 (en) | 2012-06-19 |
CL2007003482A1 (es) | 2008-07-04 |
CA2670674A1 (fr) | 2008-06-12 |
US20080139553A1 (en) | 2008-06-12 |
EP2102207B1 (fr) | 2010-06-02 |
MX2009005504A (es) | 2009-06-03 |
DE602007006990D1 (de) | 2010-07-15 |
AR064135A1 (es) | 2009-03-18 |
ATE469900T1 (de) | 2010-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200800320B (en) | Indol-3-carbonyl-spiro-piperidine derivatives as Via receptor antagonists | |
IL202665A0 (en) | Piperidine derivatives useful as orexin receptor antagonists | |
EP2099454A4 (fr) | Aminopyrrolidines utilisés en tant qu'antagonistes du récepteur de la chimiokine | |
IL205665A0 (en) | Heteroaryl derivatives as orexin receptor antagonists | |
EP2058304A4 (fr) | Antagoniste du récepteur p2x4 | |
IL195110A0 (en) | Substituted spirocyclic cgrp receptor antagonists | |
IL201112A0 (en) | Thiazolidine derivatives as orexin receptor antagonists | |
IL199015A0 (en) | Quinuclidinol derivatives as muscarinic receptor antagonists | |
ZA200902187B (en) | 8-Ethinylxanthine derivatives as selective A2A receptor antagonists | |
IL200804A0 (en) | Substituted imidazopyridine derivatives as melanocortin-4 receptor antagonists | |
AP1983A (en) | Carboxamide derivatives as muscarinic receptor antagonists | |
HK1136302A1 (en) | Progesterone receptor antagonists | |
AP2008004441A0 (en) | Piperdin-4-ylpyrazin-2-ylamine derivatives as fastdissociating dopamine 2 receptor antagonists | |
AP2006003840A0 (en) | Indole-2-carboxamidine derivatives as NMDA receptor antagonists | |
IL192308A0 (en) | Oxazoloisoquinoline derivatives as thrombin receptor antagonists | |
IL178622A0 (en) | Piperazinylpiperidine derivatives as chemokine receptor antagonists | |
IL198542A0 (en) | 2-aminoquinolines as 5-ht(5a)receptor antagonists | |
PL1912976T3 (pl) | Pochodne indol-3-ilokarbonylopiperydynobenzoimidazolu jako antagoniści receptora V1a | |
IL205949A0 (en) | 3-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists | |
HUP0501169A2 (en) | New phenantridine derivatives as selective bradykinin b1 receptor antagonists | |
ZA200903499B (en) | Indoles which act as via receptor antagonists | |
ZA200903496B (en) | Spiro-piperidine derivatives as via receptor antagonists | |
ZA200802339B (en) | Indol-3-yl-carbonyl-azaspiro derivatives as vasopressin receptor antagonists | |
IL193294A0 (en) | Piperidine derivatives as cxcr3 receptor antagonists | |
IL193295A0 (en) | Piperidine derivatives as cxcr3 receptor antagonists |